Multiple endocrine neoplasia type 2 pathophysiology: Difference between revisions

	Multiple endocrine neoplasia type 2 Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 2 from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria
History & Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Multiple endocrine neoplasia type 2 pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple endocrine neoplasia type 2 pathophysiology
CDC on Multiple endocrine neoplasia type 2 pathophysiology
Multiple endocrine neoplasia type 2 pathophysiology in the news
Blogs on Multiple endocrine neoplasia type 2 pathophysiology
Directions to Hospitals Treating Multiple endocrine neoplasia type 2
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 pathophysiology

Revision as of 18:11, 20 January 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 1: / Line 1: @@
 {{Multiple endocrine neoplasia type 2}}
 {{CMG}}
-==Natural History==
-Although many different types of hormone-producing tumors are associated with multiple endocrine neoplasia, the most common sign of multiple endocrine neoplasia type 2 is a form of [[thyroid]] cancer called [[thyroid cancer#medullary thyroid cancer (MTC)|medullary thyroid carcinoma]]. This tumor secretes an inactive hormone called [[calcitonin]]. Many people with this disorder also develop [[pheochromocytoma]], which is a [[tumor]] of the [[adrenal gland]]s (located above each [[kidney]]) that can cause dangerously high [[blood pressure]]. In addition, overactivity of the [[parathyroid gland]] ([[hyperparathyroidism]]) occurs in some cases of [[multiple endocrine neoplasia type 2]]. [[Hyperparathyroidism]] disrupts the normal balance of [[calcium]] in the blood, which can lead to [[kidney stones]], thinning of [[bone]]s, [[weakness]], and [[fatigue]].
 ==References==